European Institute of Oncology: Neoplasms trials
The registry lists 10 Neoplasms studies with European Institute of Oncology as lead sponsor. 9 are open to participants now and 0 have results posted.
Phase 2 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Disparities in Mental Health Screening and SupportRecruitingNCT07691281
- Patient Anxiety During Magnetic Resonance ImagingRecruitingNCT07671846
- EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine NeoplasmsRecruitingNCT06785597
- Radiotherapy Treatments for Neoplasms in the Head and Neck RegionRecruitingNCT06335342
- Radiotherapy Treatments for Neoplasms in the Abdominal-pelvic RegionRecruitingNCT06335238
- Evaluation of a Music and Interaction Intervention on Patient Distress During Whole Body Magnetic ResonanceRecruitingNCT06332001
- Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal SpecimensRecruitingNCT06327568
- MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung CancerRecruitingNCT05974475
- Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe StudyRecruitingNCT05554003Phase 2
- Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET)Status unknownNCT04720391